Songjiang Ma, President at GYRE THERAPEUTICS, INC. (GYRE), sold 4,000 shares at $11.52 ($45K) on 2025-02-24, disclosed to the SEC on 2025-02-25.
Scheduled sale ($45k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.84 | 1,818 | $22K | 47.6% |
| 2 | $12.60 | 182 | $2K | 5.1% |
| 3 | $10.60 | 1,813 | $19K | 42.5% |
| 4 | $11.52 | 187 | $2K | 4.8% |
| Total | $11.30 avg | 4,000 | $45K | 100% |
| Filing → |
| GYRE | SELL | 2025-05-22 | $44K | — | Filing → |
| GYRE | SELL | 2025-05-20 | $45K | — | Filing → |
| GYRE | SELL | 2025-05-16 | $22K | — | Filing → |